Eventide Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $26.1M | Hold |
|
|||||
|
2023
Q2 | $21.7M | Buy |
|
|||||
|
2023
Q1 | $13.8M | Buy |
|
|||||
|
2022
Q4 | $9.23M | Hold |
|
|||||
|
2022
Q3 | $14.2M | Buy |
|
|||||
|
2022
Q2 | $7.59M | Sell |
|
|||||
|
2022
Q1 | $37.3M | Buy |
|
|||||
|
2021
Q4 | $42.8M | Buy |
|
|||||
|
2021
Q3 | $22.9M | Hold |
|
|||||
|
2021
Q2 | $20.9M | Hold |
|
|||||
|
2021
Q1 | $22.2M | Hold |
|
|||||
|
2020
Q4 | $28.4M | Sell |
|
|||||
|
2020
Q3 | $50M | Hold |
|
|||||
|
2020
Q2 | $34.4M | Hold |
|
|||||
|
2020
Q1 | $23.1M | Hold |
|
|||||
|
2019
Q4 | $38.8M | Hold |
|
|||||
|
2019
Q3 | $23.5M | Buy |
|
|||||
|
2019
Q2 | $25M | Buy |
|